Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring
- 1 March 1999
- journal article
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 4 (1), 3-8
- https://doi.org/10.1177/107424849900400102
Abstract
Background: The VA Stroke Prevention in Nonrheumatic Atrial Fibrillation study was a prospective, randomized, double-blind study comparing low-dose warfarin with placebo in patients with nonrheumatic atrial fibrillation. The trial showed a 79% reduction in stroke rate in warfarin randomized patients without an increase in bleeding complications. We examined the need for frequent prothrombin time monitoring (international normalized ratios [INR] were not measured directly) in patients receiving warfarin.This publication has 15 references indexed in Scilit:
- Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarctionThe Lancet, 1997
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996
- An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1996
- Anticoagulation in Atrial FibrillationArchives of Internal Medicine, 1994
- Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial FibrillationArchives of Internal Medicine, 1994
- A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve ReplacementNew England Journal of Medicine, 1993
- Risk Factors for Complications of Chronic Anticoagulation: A Multicenter StudyAnnals of Internal Medicine, 1993
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Home Prothrombin Time Monitoring after the Initiation of Warfarin TherapyAnnals of Internal Medicine, 1989
- Cost Effectiveness of Monitoring Warfarin Therapy Using Standard Versus Capillary Prothrombin TimesAmerican Journal of Clinical Pathology, 1989